Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm

Perkins, D, Sarris, J, Rossell, S, Bonomo, Y, Forbes, D, Davey, C, Hoyer, D, Loo, C, Murray, G, Hood, S, Schubert, V, Galvão-Coelho, NL, O’Donnell, M, Carter, O, Liknaitzky, Paul, Williams, M, Siskind, D, Penington, D, Berk, Michael and Castle, D 2021, Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm, Australian and New Zealand Journal of Psychiatry, pp. 1-7, doi: 10.1177/0004867421998785.

Attached Files
Name Description MIMEType Size Downloads

Title Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm
Author(s) Perkins, D
Sarris, J
Rossell, S
Bonomo, Y
Forbes, D
Davey, C
Hoyer, D
Loo, C
Murray, G
Hood, S
Schubert, V
Galvão-Coelho, NL
O’Donnell, M
Carter, O
Liknaitzky, PaulORCID iD for Liknaitzky, Paul orcid.org/0000-0001-5690-2263
Williams, M
Siskind, D
Penington, D
Berk, MichaelORCID iD for Berk, Michael orcid.org/0000-0002-5554-6946
Castle, D
Journal name Australian and New Zealand Journal of Psychiatry
Start page 1
End page 7
Total pages 7
Publisher SAGE Publications
Place of publication London, Eng.
Publication date 2021-03-21
ISSN 0004-8674
1440-1614
Keyword(s) ayahuasca
depression
Life Sciences & Biomedicine
LSD
MDMA
mental disorders
neuroscience
post-traumatic stress disorder
psilocybin
Psychedelic-assisted psychotherapy
psychiatry
Science & Technology
Summary The medical use of psychedelic substances (e.g. psilocybin, ayahuasca, lysergic acid diethylamide and 3,4-methylenedioxymethamphetamine) is attracting renewed interest, driven by a pressing need for research and development of novel therapies for psychiatric disorders, as well as promising results of contemporary studies. In this Viewpoint, we reflect upon the ‘Clinical Memorandum on Psychedelics’ recently released by the Royal Australian and New Zealand College of Psychiatrists and note subsequent developments including the application for down-scheduling of psilocybin and 3,4-methylenedioxymethamphetamine presently being considered by the Therapeutic Goods Administration and approvals for access via the Special Access Scheme. We suggest that this field is worthy of rigorous research to assess potential benefits, address safety parameters and clarify therapeutic mechanisms. To this end, we outline recent research findings, provide an overview of current knowledge relating to mechanisms of action and discuss salient aspects of the psychedelic-assisted psychotherapy treatment model. The sum of this research points towards medicinal psychedelics as a potential new class of psychiatric treatments when used within a medically supervised framework with integrated psychotherapeutic support. However, before widespread translation into clinical use can occur, appropriately designed and sufficiently powered trials are required to detect both potential positive and negative outcomes. Unique safety and regulatory challenges also need to be addressed. As for any new medical therapy, psychedelic research needs to be conducted in a rigorous manner, through the dispassionate lens of scientific enquiry. Carte blanche availability to practitioners, without specific protocols and appropriate training, would be potentially harmful to individuals and detrimental to the field.
Notes In Press
Language eng
DOI 10.1177/0004867421998785
Indigenous content off
Field of Research 110999 Neurosciences not elsewhere classified
11 Medical and Health Sciences
17 Psychology and Cognitive Sciences
Socio Economic Objective 920410 Mental Health
HERDC Research category C1 Refereed article in a scholarly journal
Persistent URL http://hdl.handle.net/10536/DRO/DU:30149521

Document type: Journal Article
Collections: Faculty of Health
School of Psychology
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 2 times in TR Web of Science
Scopus Citation Count Cited 2 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 23 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Tue, 01 Jun 2021, 12:36:33 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.